Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
 Applauds Gov. Brown on Budget that Invests $10 Million in Precision Medicine Research - EconoTimes)
SOUTH SAN FRANCISCO & SAN DIEGO, Jan. 8, 2016 (GLOBE NEWSWIRE) -- The California Life Sciences Association (CLSA) today issued the following statement from CLSA President & CEO Sara Radcliffe applauding Gov. Jerry Brown's 2016 – 2017 budget proposal that includes $10 million for precision medicine research. CLSA is the leading voice to drive innovation for California's life sciences sector, serving over 750 life sciences organizations across California.
"California Life Sciences Association (CLSA) applauds Governor Jerry Brown and his Administration for their unwavering support of life sciences innovation, as demonstrated again in this year's budget which calls for a $10 million investment in precision medicine research. California is the birthplace of biotechnology and today the state's life sciences sector employs over 281,000 people working to develop innovative new medicines, technologies and therapies needed to treat and cure patients.
"We look forward to working with the Governor to best invest these research dollars to better understand and combat disease in the 21st century. Many CLSA member companies, universities and research institutes are already working in the precision medicine space and we applaud Governor Brown for his thoughtful and visionary support to advance this important research here in California."
Click here to view the budget proposal.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice for California's life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California's life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state's most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
CONTACT: Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848
